Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 6,670 | 5,696 | 6,302 | 4,655 | 3,856 |
| Cost of Goods | 5,199 | 4,835 | 6,064 | 3,501 | 2,417 |
| Gross Profit | 1,471 | 861 | 238 | 1,154 | 1,439 |
| Operating Expenses | 33,749 | 31,639 | 29,086 | 22,333 | 18,332 |
| Operating Income | -32,079 | -29,943 | -28,784 | -20,678 | -16,476 |
| Interest Expense | 74 | 77 | 54 | 2 | 268 |
| Other Income | 36 | 77 | 122 | -38 | -2,033 |
| Pre-tax Income | -32,117 | -29,943 | -28,716 | -20,718 | -18,777 |
| Income Tax | 41 | 9 | -5,767 | 35 | 9 |
| Net Income Continuous | -32,158 | -29,952 | -22,949 | -20,753 | -18,786 |
| Net Income | $-32,158 | $-29,952 | $-22,949 | $-20,753 | $-18,786 |
| EPS Basic Total Ops | -67.66 | -65.87 | -47.90 | -41.92 | -41.92 |
| EPS Basic Continuous Ops | -67.44 | -63.02 | -49.45 | -44.35 | -40.33 |
| EPS Diluted Total Ops | -67.66 | -65.87 | -47.90 | -41.92 | -41.92 |
| EPS Diluted Continuous Ops | -67.44 | -63.02 | -49.45 | -44.35 | -40.33 |
| EBITDA(a) | $-29,474 | $-27,405 | $-26,575 | $-20,152 | $-15,960 |